This Week's HealthTech Earnings Report: Starting Today, May 23rd
May 23rd, 2022 (Earnings Report)Dear Reader,HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings this week.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Genetron Holdings
Symbol: GTH
Recent Price: $$1.38
Average Analyst Price Target: $10.00 (624.64%)
Last Year's EPS: -$0.25
Consensus EPS Forecast: -$0.27
Expected Earnings Date: May 22 2022
Recent Analyst Action: Sung Ji, analyst at BTIG, reiterates coverage on Genetron Holdings (GTH) in the Healthcare sector with a Buy rating and a price target of $ 10 (1 month ago).
TipRanks.com also reports that Genetron Holdings currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00 . The target pricing ranges from a high forecast of $10.00 down to a low forecast of $10.00. Genetron Holdings (GTH)’s last closing price was $$1.38 which would put the average price target at 624.64% upside.Click for complete article >>
--------------------------------------------------------------------------
*ReShape Lifesciences
Symbol: RSLS
Recent Price: $$0.82
Average Analyst Price Target: $4.00 (390.20%)
Last Year's EPS: -$1.32
Consensus EPS Forecast: -$0.35
Expected Earnings Date: May 22 2022
Recent Analyst Action: Anthony Vendetti, analyst at Maxim Group, reiterates coverage on ReShape Lifesciences (RSLS) in the Healthcare sector with a Buy rating and a price target of $ 4 (1 month ago).
TipRanks.com also reports that ReShape Lifesciences currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.00 down to a low forecast of $4.00. ReShape Lifesciences (RSLS)’s last closing price was $$0.82 which would put the average price target at 390.20% upside.Click for complete article >>
--------------------------------------------------------------------------
Star Equity Holdings
Symbol: STRR
Recent Price: $$0.78
Average Analyst Price Target: $3.50 (351.50%)
Last Year's EPS: -$0.35
Consensus EPS Forecast: -$0.15
Expected Earnings Date: May 22 2022
Recent Analyst Action: Tate Sullivan, analyst at Maxim Group, reiterates coverage on Star Equity Holdings (STRR) in the Healthcare sector with a Buy rating and a price target of $ 3.5 (2 months ago).
TipRanks.com also reports that Star Equity Holdings currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.50 . The target pricing ranges from a high forecast of $3.50 down to a low forecast of $3.50. Star Equity Holdings (STRR)’s last closing price was $$0.78 which would put the average price target at 351.50% upside.Click for complete article >>
--------------------------------------------------------------------------
Agilent
Symbol: A
Recent Price: $$125.13
Average Analyst Price Target: $146.67 (17.21%)
Last Year's EPS: $0.97
Consensus EPS Forecast: $1.12
Expected Earnings Date: May 23 2022
Recent Analyst Action: Patrick B, analyst at Citigroup, reiterates coverage on Agilent (A) in the Healthcare sector with a Buy rating and a price target of $ 175 (1 week ago).
TipRanks.com also reports that Agilent currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $146.67 . The target pricing ranges from a high forecast of $175.00 down to a low forecast of $130.00. Agilent (A)’s last closing price was $$125.13 which would put the average price target at 17.21% upside.Click for complete article >>
--------------------------------------------------------------------------
Taro Pharmaceutical
Symbol: TARO
Recent Price: $$37.60
Average Analyst Price Target: $73.00 (94.15%)
Last Year's EPS: -$0.78
Consensus EPS Forecast: $0.88
Expected Earnings Date: May 23 2022
Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on Taro Pharmaceutical (TARO) in the Healthcare sector with a Buy rating and a price target of $ 73 (2 months ago).
TipRanks.com also reports that Taro Pharmaceutical currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $73.00 . The target pricing ranges from a high forecast of $73.00 down to a low forecast of $73.00. Taro Pharmaceutical (TARO)’s last closing price was $$37.60 which would put the average price target at 94.15% upside.Click for complete article >>
--------------------------------------------------------------------------
Rubicon Organics
Symbol: ROMJF
Recent Price: $$0.75
Average Analyst Price Target: $2.73 (262.62%)
Last Year's EPS: -$0.06
Consensus EPS Forecast: ―
Expected Earnings Date: May 23 2022
Recent Analyst Action: Rahul Sarugaser, analyst at Raymond James, reiterates coverage on Rubicon Organics (ROMJF) in the Healthcare sector with a Buy rating and a price target of $ 2.73 (1 month ago).
TipRanks.com also reports that Rubicon Organics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.73 . The target pricing ranges from a high forecast of $2.73 down to a low forecast of $2.73. Rubicon Organics (ROMJF)’s last closing price was $$0.75 which would put the average price target at 262.62% upside.Click for complete article >>
--------------------------------------------------------------------------
*Editor has position in this security.
To Your Financial Future,
The Editor, HealthTechMovers.com